You have no items in your shopping cart.
Human STAT3 ELISA Kit
Description
Research Area
Images & Validation
−Key Properties
−| Reactivity | Human |
|---|---|
| Sample Types | Serum,Plasma,Cell Culture Supernatant,Cell or tissue lysate,Other liquid samples |
| Assay Type | Sandwich |
| Assay Time | 4 hours |
| Range | 0.313-20ng/ml |
| Sensitivity | 0.188ng/ml |
Procedure & Performance
−| Assay Principle | |
|---|---|
| Kit Components | |
| Reagent Preparation | |
| Assay Procedure | |
| Materials Required | |
| Precision | |
| Calculation of Results | |
| Curve Fitting Softwares |
Storage & Handling
−| Storage | 2 - 8 °C for 12 months |
|---|---|
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Human Signal Transducer and Activator of Transcription 3 (STAT3) ELISA Kit [orb779395]
Human
0.16-10 ng/mL
0.064 ng/mL
48 T, 96 THuman Protein Inhibitor of Activated STAT3 (PIAS3) ELISA Kit [orb1949336]
Human
62.5-4000pg/mL
37.5 pg/mL
48 T, 96 THuman STAT3 (Signal transducer and activator of transcription 3) Quick ELISA Kit [orb2568470]
Human
0.313-20ng/ml
0.188ng/ml
48 T, 96 TFS-Human STAT3(Signal Transducer And Activator Of Transcription 3) ELISA Kit [orb3197162]
Human
78.13-5000pg/mL
34.92pg/mL
48 T, 96 TFS-Human PIAS3(Protein Inhibitor of Activated STAT3) ELISA Kit [orb3190713]
Human
62.5-4000pg/mL
30.31pg/mL
48 T, 96 T

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−Protocol Information
Filter by Applications
Filter by Species
Elbakry, Mustafa M. M. et al. Pomegranate Peel Extract Sensitizes Hepatocellular Carcinoma Cells to Ionizing Radiation, Induces Apoptosis and Inhibits MAPK, JAK/STAT3, ?-Catenin/NOTCH, and SOCS3 Signaling Integr Cancer Ther, 22, (2023)
Applications
Reactivity




